NO159528C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.

Info

Publication number
NO159528C
NO159528C NO844978A NO844978A NO159528C NO 159528 C NO159528 C NO 159528C NO 844978 A NO844978 A NO 844978A NO 844978 A NO844978 A NO 844978A NO 159528 C NO159528 C NO 159528C
Authority
NO
Norway
Prior art keywords
aminoguanide
ingredients
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO844978A
Other languages
English (en)
Norwegian (no)
Other versions
NO844978L (no
NO159528B (no
Inventor
Istvan Erczi
Jenoe Marosfalvi
Gyoergy Rabloczky
Andras Varro
Maria Kuhar
Istvan Elekes
Laszlo Szatamary
Laszlo Jaszlits
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of NO844978L publication Critical patent/NO844978L/no
Publication of NO159528B publication Critical patent/NO159528B/no
Publication of NO159528C publication Critical patent/NO159528C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
    • C07C281/08—Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones
    • C07C281/10—Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones the carbon atom being further bound to an acyclic carbon atom or to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO844978A 1983-12-12 1984-12-12 Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater. NO159528C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU834222A HU190639B (en) 1983-12-12 1983-12-12 Process for production of new aminoguanidin derivatives

Publications (3)

Publication Number Publication Date
NO844978L NO844978L (no) 1985-06-13
NO159528B NO159528B (no) 1988-10-03
NO159528C true NO159528C (no) 1989-01-11

Family

ID=10967376

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844978A NO159528C (no) 1983-12-12 1984-12-12 Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.

Country Status (21)

Country Link
US (1) US4731383A (ro)
JP (1) JPS60178855A (ro)
KR (1) KR870001105B1 (ro)
AT (1) AT394192B (ro)
BE (1) BE901239A (ro)
BG (3) BG44374A3 (ro)
CA (1) CA1237129A (ro)
CH (1) CH664955A5 (ro)
DD (1) DD228246A5 (ro)
DE (1) DE3445339A1 (ro)
DK (1) DK164155C (ro)
FI (1) FI79527C (ro)
FR (1) FR2556343B1 (ro)
GB (1) GB2151617B (ro)
HU (1) HU190639B (ro)
IL (1) IL73811A (ro)
NL (1) NL193539C (ro)
NO (1) NO159528C (ro)
PL (2) PL140594B1 (ro)
SE (1) SE462847B (ro)
SU (2) SU1340583A3 (ro)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852009A (en) * 1984-03-19 1998-12-22 The Rockefeller University Compositions, including pharmaceutical compositions, for inhibiting the advanced glycosylation of proteins, and therapeutic methods based thereon
US5612332A (en) * 1984-03-19 1997-03-18 Alteon Inc. Di- and triaminoguanidines, and methods of use
FR2669927B1 (fr) * 1990-11-29 1994-04-08 Adir Cie Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5424449A (en) * 1994-10-28 1995-06-13 Olin Corporation Process for the preparation of 5-aminotetrazole
US5850840A (en) * 1995-11-15 1998-12-22 Alteon Inc. Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
US6110968A (en) * 1995-12-26 2000-08-29 The Picower Institute For Medical Research Methods for treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
US5877217A (en) * 1995-12-26 1999-03-02 Alteon Inc. N-acylaminoalkyl-hydrazinecarboximidamides
AT405180B (de) * 1997-04-01 1999-06-25 Biochemie Gmbh Neue derivate von substituierten 3-cephem-4-carbonsäurederivaten und verfahren zu deren herstellung
EP0973780B1 (en) * 1997-04-01 2003-07-02 Biochemie Gesellschaft M.B.H. Antibacterial substituted 7-acylamino -3-(methylhydrazono) methyl-cephalosporins and intermediates
US20020115852A1 (en) 1997-04-01 2002-08-22 Gerd Ascher Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
FR2771409B1 (fr) * 1997-11-21 2000-01-14 Oreal Nouveaux composes azoiques, utilisation pour la teinture, compositions les contenant et procedes de teinture
US6883592B2 (en) 1998-11-04 2005-04-26 Zalman Tech Co., Ltd. Heatsink for electronic component
US7180758B2 (en) 1999-07-22 2007-02-20 Mks Instruments, Inc. Class E amplifier with inductive clamp
FR2804428B1 (fr) * 2000-01-27 2002-03-22 Oreal Nouvelles bases d'oxydation a chaine guanidine, leur procede de preparation, leur utilisation pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procedes de teinture
ITRM20020625A1 (it) * 2002-12-17 2004-06-18 Sigma Tau Ind Farmaceuti Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE663481A (ro) * 1964-05-05
GB1274668A (en) * 1968-06-10 1972-05-17 Ici Ltd Pesticidal compositions comprising aminoguanidines
DE1768867C3 (de) * 1968-07-09 1973-12-20 Boehringer Mannheim Gmbh, 6800 Mannheim Aminoguanidin-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von Arzneimitteln
US3803324A (en) * 1968-07-09 1974-04-09 Boehringer Mannheim Gmbh Amino-guanidine derivatives useful for regulating blood pressure
DE1939738A1 (de) * 1969-08-05 1971-02-18 Boehringer Mannheim Gmbh Aminoguanidine und Verfahren zur Herstellung derselben
NL7315350A (nl) * 1973-11-09 1975-05-13 Akzo Nv Nieuwe aminoguanidine verbindingen.

Also Published As

Publication number Publication date
NL8403779A (nl) 1985-07-01
SE8406302D0 (sv) 1984-12-12
FI79527B (fi) 1989-09-29
HUT36089A (en) 1985-08-28
AT394192B (de) 1992-02-10
FI79527C (fi) 1990-01-10
NL193539C (nl) 2000-01-04
FI844909A0 (fi) 1984-12-12
DE3445339A1 (de) 1985-06-13
CH664955A5 (de) 1988-04-15
GB2151617B (en) 1987-06-10
BG42355A3 (en) 1987-11-14
FR2556343A1 (fr) 1985-06-14
IL73811A0 (en) 1985-03-31
PL255440A1 (en) 1986-07-01
SU1498383A3 (ru) 1989-07-30
PL142626B1 (en) 1987-11-30
FI844909L (fi) 1985-06-13
BG44374A3 (en) 1988-11-15
NL193539B (nl) 1999-09-01
SE462847B (sv) 1990-09-10
IL73811A (en) 1988-12-30
GB8431312D0 (en) 1985-01-23
BG60757B2 (bg) 1996-02-29
DK164155B (da) 1992-05-18
DK595484A (da) 1985-06-13
CA1237129A (en) 1988-05-24
KR850004585A (ko) 1985-07-25
HU190639B (en) 1986-09-29
ATA392384A (de) 1991-08-15
NO844978L (no) 1985-06-13
DK164155C (da) 1992-10-12
US4731383A (en) 1988-03-15
DE3445339C2 (ro) 1989-12-14
DK595484D0 (da) 1984-12-12
GB2151617A (en) 1985-07-24
PL250892A1 (en) 1985-12-17
NO159528B (no) 1988-10-03
BE901239A (fr) 1985-06-10
JPH0226629B2 (ro) 1990-06-12
DD228246A5 (de) 1985-10-09
FR2556343B1 (fr) 1988-03-04
SU1340583A3 (ru) 1987-09-23
PL140594B1 (en) 1987-05-30
KR870001105B1 (ko) 1987-06-08
JPS60178855A (ja) 1985-09-12
SE8406302L (sv) 1985-06-13

Similar Documents

Publication Publication Date Title
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO161679C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO163693C (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.
NO883750D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO164415C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.